In the ED, she was noted to have stable vitals, although potassium was 2.4.
Locally-advanced pancreatic cancer - Initially diagnosed in [**2162**] by abdominal ultrasound in the setting of crampy abdominal pain.
She commenced XelOX on [**12-19**], Oxaliplatin 100 mg/m2 every 21 days and capecitabice (Xeloda) 1000 mg/m2 [**Hospital1 **] for 14 of 21 days.
Physical Exam: VS: Temp: 98.3  BP: 120/70 HR: 83 RR: 16  sat 96RA GEN: awake, alert, NAD, hard of hearing HEENT: surgical pupils, EOMI, anicteric, MM slightly dry NECK: JVP flat no supraclavicular or cervical lymphadenopathy, CHEST: port in place, c/d/i, CTAB CV: RR, S1 and S2 wnl, no m/r/g ABD: nd, +b/s, soft, mild TTP diffusely EXT: no c/c/e SKIN: no rashes/no jaundice   Pertinent Results: [**2166-1-15**] 10:15AM   WBC-4.0 RBC-4.04* HGB-11.1* HCT-32.9* MCV-81* MCH-27.4 MCHC-33.7 RDW-17.1* [**2166-1-15**] 10:15AM   NEUTS-55 BANDS-15* LYMPHS-15* MONOS-14* EOS-0 BASOS-0 ATYPS-0 METAS-0 MYELOS-1* [**2166-1-15**] 10:15AM   PLT SMR-LOW PLT COUNT-110* [**2166-1-15**] 10:15AM   PT-18.3* PTT-26.9 INR(PT)-1.7* [**2166-1-15**] 10:15AM   GLUCOSE-103 UREA N-11 CREAT-0.7 SODIUM-135 POTASSIUM-2.4* CHLORIDE-97 TOTAL CO2-25 ANION GAP-15 [**2166-1-15**] 10:15AM   CALCIUM-8.0* PHOSPHATE-2.0*# MAGNESIUM-1.8 [**2166-1-15**] 10:29AM   LACTATE-1.5 K+-2.4* [**2166-1-15**] 01:15PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-150 BILIRUBIN-SM UROBILNGN-NEG PH-6.5 LEUK-TR [**2166-1-15**] 01:15PM URINE  RBC-[**2-26**]* WBC-[**6-3**]* BACTERIA-OCC YEAST-NONE EPI-0-2 [**2166-1-15**] 08:31PM   WBC-4.4 RBC-3.63* HGB-9.9* HCT-30.5* MCV-84 MCH-27.3 MCHC-32.6 RDW-18.1* [**2166-1-15**] 08:31PM   PLT COUNT-108* [**2166-1-15**] 08:31PM   MAGNESIUM-1.8 [**2166-1-15**] 08:45PM   UREA N-9 CREAT-0.7 POTASSIUM-3.0* [**2166-1-20**] 12:00AM BLOOD WBC-11.3* RBC-4.31 Hgb-12.1 Hct-36.7 MCV-85 MCH-28.1 MCHC-32.9 RDW-19.0* Plt Ct-218 [**2166-1-25**] 12:00AM BLOOD WBC-16.1*# RBC-4.53 Hgb-12.2 Hct-38.6 MCV-85 MCH-26.9* MCHC-31.6 RDW-20.0* Plt Ct-211 [**2166-1-26**] 12:00AM BLOOD WBC-18.4* RBC-4.69 Hgb-12.4 Hct-39.7 MCV-85 MCH-26.4* MCHC-31.2 RDW-19.9* Plt Ct-129* [**2166-1-26**] 07:50AM BLOOD WBC-10.2 RBC-3.43*# Hgb-9.1*# Hct-28.6*# MCV-83 MCH-26.6* MCHC-31.9 RDW-20.8* Plt Ct-79* [**2166-1-29**] 03:10AM BLOOD WBC-4.0 RBC-2.31* Hgb-6.4* Hct-19.9* MCV-86 MCH-27.8 MCHC-32.3 RDW-19.3* Plt Ct-35* [**2166-1-26**] 12:00AM BLOOD Neuts-41* Bands-33* Lymphs-8* Monos-7 Eos-0 Baso-2 Atyps-2* Metas-3* Myelos-4* [**2166-1-15**] 10:15AM BLOOD Neuts-55 Bands-15* Lymphs-15* Monos-14* Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-1* [**2166-1-27**] 06:24PM BLOOD Neuts-90* Bands-2 Lymphs-6* Monos-1* Eos-1 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2166-1-15**] 10:15AM BLOOD PT-18.3* PTT-26.9 INR(PT)-1.7* [**2166-1-19**] 12:11AM BLOOD PT-37.1* PTT-33.0 INR(PT)-4.0* [**2166-1-22**] 05:41AM BLOOD PT-13.3 PTT-24.3 INR(PT)-1.1 [**2166-1-28**] 05:12AM BLOOD PT-39.4* PTT-45.9* INR(PT)-4.3* [**2166-1-29**] 03:10AM BLOOD PT-17.7* PTT-36.8* INR(PT)-1.6* [**2166-1-27**] 05:17PM BLOOD Fibrino-578* D-Dimer-2090* [**2166-1-17**] 12:15AM BLOOD Glucose-115* UreaN-9 Creat-0.8 Na-145 K-3.6 Cl-116* HCO3-18* AnGap-15 [**2166-1-26**] 12:00AM BLOOD Glucose-167* UreaN-69* Creat-1.6* Na-143 K-4.0 Cl-108 HCO3-18* AnGap-21* [**2166-1-29**] 03:10AM BLOOD Glucose-138* UreaN-26* Creat-0.9 Na-146* K-3.4 Cl-112* HCO3-29 AnGap-8 [**2166-1-22**] 05:41AM BLOOD ALT-7 AST-10 LD(LDH)-171 AlkPhos-52 Amylase-7 TotBili-0.4 [**2166-1-26**] 05:17AM BLOOD ALT-25 AST-39 CK(CPK)-176* AlkPhos-103 Amylase-16 TotBili-0.8 [**2166-1-26**] 12:57PM BLOOD LD(LDH)-352* CK(CPK)-157* TotBili-1.1 [**2166-1-26**] 08:45PM BLOOD LD(LDH)-307* CK(CPK)-112 [**2166-1-26**] 05:17AM BLOOD CK-MB-12* MB Indx-6.8* cTropnT-0.03* [**2166-1-26**] 12:57PM BLOOD CK-MB-9 cTropnT-0.02* [**2166-1-26**] 08:45PM BLOOD CK-MB-8 cTropnT-0.03* [**2166-1-15**] 10:15AM BLOOD Calcium-8.0* Phos-2.0*# Mg-1.8 [**2166-1-29**] 03:10AM BLOOD Calcium-7.1* Phos-2.5* Mg-2.1 [**2166-1-26**] 07:54AM BLOOD Cortsol-114.7*  ECG Study Date of [**2166-1-15**]  10:23:46 AM Baseline artifact.
Compared to the previous tracing of [**2165-11-27**] no significant change.
CT Abdomen/Pelvis [**2166-1-25**]: 1.
Occlusion of the portosplenic confluence with venous collaterals, unchanged since [**10-31**].
CXR [**2166-1-26**]: There is a new right IJ line with tip in SVC.
CT Head [**2166-1-27**]: No CT evidence of an acute territorial infarct.
CXR [**2166-1-28**]: Slight increase in pulmonary edema; similar appearance of bilateral moderate pleural effusions.
She was given IV Fluids, prn antiemetics, and her electrolytes were corrected prn.
Blood pressure was supported with levophed.
CTA was not done given patient's worsening renal function and unstable clinical status.
# Coagulopathy: Patient's INR increased during admission despite holding coumadin.
DIC labs were negative.
Patient's INR improved with FFP and vitamin K.  #.
